Who Owns INHIBIKASE THERAPEUTICS INC (IKT)? -- Institutional Holders (2026-03-31)

112 institutions reported holding $197.9M of INHIBIKASE THERAPEUTICS INC (IKT) in SEC 13F filings for 2026-03-31. Largest institutional holders: Sands Capital Alternatives, LLC ($21.9M), Soleus Capital Management, L.P. ($18.3M), Fairmount Funds Management LLC ($14.5M), Trails Edge Capital Partners, LP ($13.5M), ADAR1 Capital Management, LLC ($11.1M). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1Sands Capital Alternatives, LLC$21.9M13.0MHold
2Soleus Capital Management, L.P.$18.3M10.9MHold
3Fairmount Funds Management LLC$14.5M8.6MHold
4Trails Edge Capital Partners, LP$13.5M8.1MAdded
5ADAR1 Capital Management, LLC$11.1M6.6MTrimmed
6Kalehua Capital Management LLC$10.9M6.5MAdded
7BlackRock, Inc.$10.6M6.3MAdded
8Blackstone Inc.$10.0M5.9MHold
9Siren, L.L.C.$9.8M5.8MHold
10Commodore Capital LP$9.1M5.4MHold
11VANGUARD CAPITAL MANAGEMENT LLC$7.5M4.5MNew
12Saturn V Capital Management LP$6.5M3.9MAdded
13Spruce Street Capital LP$6.0M3.6MHold
14Squadron Capital Management LLC$5.9M3.5MTrimmed
15MILLENNIUM MANAGEMENT LLC$4.9M2.9MAdded
16Nantahala Capital Management, LLC$4.5M2.7MTrimmed
17PERCEPTIVE ADVISORS LLC$3.9M2.3MTrimmed
18GEODE CAPITAL MANAGEMENT, LLC$3.6M2.2MAdded
19STATE STREET CORP$2.8M1.7MAdded
20SummitTX Capital, L.P.$2.6M1.5MNew
21Integral Health Asset Management, LLC$2.3M1.4MTrimmed
22Ally Bridge Group (NY) LLC$2.2M1.3MNew
23CITADEL ADVISORS LLC$1.9M1.1MTrimmed
24Stonepine Capital Management, LLC$1.6M957,202Trimmed
25TWO SIGMA INVESTMENTS, LP$1.4M847,611New

Source: SEC Form 13F filings · as of 2026-03-31